Dantrium Side Effects
Generic name: dantrolene
Note: This document contains side effect information about dantrolene. Some of the dosage forms listed on this page may not apply to the brand name Dantrium.
Some side effects of Dantrium may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to dantrolene: oral capsule
Get emergency medical help if you have any of these signs of an allergic reaction while taking dantrolene (the active ingredient contained in Dantrium) hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
severe diarrhea or constipation;
weak or shallow breathing;
pale skin, easy bruising or bleeding;
trouble swallowing, especially if it causes choking;
nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
black, bloody, or tarry stools;
coughing up blood or vomit that looks like coffee grounds;
seizure (black-out or convulsions); or
urinating less than usual or not at all.
Less serious side effects of dantrolene may include:
drowsiness, dizziness, weakness, tired feeling;
mild diarrhea or constipation;
mild nausea, vomiting, stomach pain;
problems with speech, balance, or walking;
headache, confusion, vision problems;
sleep problems (insomnia);
sweating, drooling; or
urinating more than usual.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to dantrolene: intravenous powder for injection, oral capsule
Nervous system side effects have commonly included drowsiness (30%), dizziness (14%), and malaise. Speech disturbances, headache, seizures and hallucinations have been reported less frequently.
Several reports of severe constipation and abdominal distention leading to functional obstruction have been reported.
Gastrointestinal side effects have frequently included diarrhea which may be severe enough to require discontinuation. Constipation, abdominal cramps, nausea, and vomiting have been reported less frequently.
Hematologic side effects have included aplastic anemia, leukopenia, and lymphocytic lymphoma.
Musculoskeletal side effects have commonly included weakness which is usually tolerable. Myalgia and backache have also been reported.
Hepatic side effects have included hepatic injury (1.8%), hepatitis (0.6%), and fatal hepatitis (0.3%).
Risk of hepatic injury is greater in females, patients over 35 years of age, and in patients on concurrent medications. The severity of the reaction appears to increase with increases in dose and duration.
Respiratory side effects have infrequently included pulmonary edema with the use of intravenous dantrolene (the active ingredient contained in Dantrium) Pleural effusion and pneumonitis have also been reported.
Cardiovascular side effects have infrequently included pericarditis (both with and without pleural effusion) in patients receiving oral dantrolene (the active ingredient contained in Dantrium) Cardiovascular side effects reported postmarketing have included heart failure.
Local side effects have included thrombophlebitis in patients receiving intravenous dantrolene (the active ingredient contained in Dantrium)
Dermatologic side effects have included rare reports of acne.
Ocular side effects have included visual disturbances.
Other side effects have included one case of bilateral hearing loss which was thought to have been secondary to dantrolene (the active ingredient contained in Dantrium) treatment.
Hypersensitivity side effects reported postmarketing have included anaphylaxis.
More Dantrium resources
- Dantrium Concise Consumer Information (Cerner Multum)
- Dantrium Prescribing Information (FDA)
- Dantrium MedFacts Consumer Leaflet (Wolters Kluwer)
- Dantrium Monograph (AHFS DI)
- Dantrium Advanced Consumer (Micromedex) - Includes Dosage Information
- Dantrolene Prescribing Information (FDA)
- Dantrium Intravenous Prescribing Information (FDA)
- Dantrium Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.